Teva Pharmaceutical Industries Limited (TLV:TEVA)
12,000
-160 (-1.32%)
Oct 5, 2026, 5:28 PM IDT
TLV:TEVA Market Cap
TLV:TEVA has a market cap or net worth of 141.24 billion as of October 5, 2026. Its market cap has increased by 83.28% in one year.
Market Cap
141.24B
Enterprise Value
181.72B
Revenue
51.58B
Ranking
n/a
PE Ratio
67.16
Stock Price
12,000.00
ChartMarket Cap Chart
Since August 12, 2003, TLV:TEVA's market cap has increased from 126.42B to 141.24B, an increase of 11.73%. That is a compound annual growth rate of 0.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 141.24B | 33.39% |
| Dec 9, 2025 | 105.89B | 38.27% |
| Dec 24, 2024 | 76.58B | 114.06% |
| Dec 13, 2023 | 35.77B | 2.46% |
| Dec 30, 2022 | 34.91B | 17.65% |
| Dec 31, 2021 | 29.68B | -10.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.23B |
| Rafa Laboratories | 1.75B |
| BrainsWay | 1.56B |
| Kamada | 1.47B |
| SofWave Medical | 1.21B |
| Bait Bakfar | 1.02B |
| Ilex Medical | 576.75M |